CN Stock MarketDetailed Quotes

002252 Shanghai RAAS Blood Products

Watchlist
  • 7.50
  • -0.22-2.85%
Market Closed Dec 13 15:00 CST
49.78BMarket Cap27.17P/E (TTM)

Shanghai RAAS Blood Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai RAAS Blood Products Q3 2024 Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
2.26B
2.06B
-194.93M
Miss Est.
--
+1.34%
-8.64%
EPS
0.10
0.09
-0.01
Miss Est.
+21.95%
--
-10.00%
Analyst Rating
Strong Buy

Dec 13, 2024

Shanghai RAAS Blood Products Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.451B--
--2024/Q4-- / 2.287B--
Oct 29, 20242024/Q32.062B / 2.257B--
Aug 28, 20242024/Q22.196B / 2.038B--
--2024/Q12.056B / 2.322B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.451B--
--2024/Q4-- / 2.287B--
Oct 29, 20242024/Q32.062B / 2.257B--
Aug 28, 20242024/Q22.196B / 2.038B--
--2024/Q12.056B / 2.322B--

Unlock Free Earnings Estimates

Shanghai RAAS Blood Products Earnings Reports

  • Shanghai Laishi: Report for the third quarter of 2024

    Oct 28 12:00 ET

  • Shanghai Rice: Semi-Annual Report 2024

    Aug 27 12:00 ET

  • Shanghai Rice: Summary of the 2024 Semi-Annual Report

    Aug 27 12:00 ET

  • Shanghai RAAS Blood Products: 2024 First Quarter Report

    Apr 29 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    KAYO MOTOR
    834058
    38.58 +29.99%
    Zhejiang Zoenn Design
    300901
    14.86 +20.03%
    Zhejiang Meorient Commerce & Exhibition Inc.
    300795
    22.36 +20.02%
    Fujian Zitian Media Technology
    300280
    22.18 +20.02%
    Zhejiang Prulde Electric Appliance
    301353
    36.46 +20.01%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 13, 2024

    Strong Buy

    • Strong Buy

      90.91%

    • Buy

      9.09%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data